Sagimet Biosciences Inc. Revenue 2023–2023
Sagimet Biosciences Inc. annual/quarterly revenue history and growth rate from 2023 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Sagimet Biosciences Inc. revenue for the quarter ending September 30, 2023 was 2.0 M.
- Sagimet Biosciences Inc. annual revenue for 2023 was 2.0 M.
Sagimet Biosciences Inc. (SGMT) — Frequently Asked Questions
Sagimet Biosciences Inc. (SGMT) is a publicly traded US company. It has a market capitalization of $68M. In fiscal 2023 it reported revenue of $2M and net income of -$28M. Explore SGMT's stock price, financial statements, earnings history, margins and key ratios below.
What is Sagimet Biosciences Inc.'s market cap?
Sagimet Biosciences Inc. (SGMT) has a market capitalization of $68M.
What is the SGMT stock price?
SGMT trades at $6.50 (-0.31% on the day).
How much revenue does Sagimet Biosciences Inc. make?
Sagimet Biosciences Inc. reported revenue of $2M in fiscal 2023.
Is SGMT profitable?
In fiscal 2023, Sagimet Biosciences Inc. reported net income of -$28M.